Building the right leadership team is crucial for any startup looking to scale beyond proof-of-concept. This webinar will overview the complexities, strategy, and timing of hiring the right executive ...

The JPMorgan Healthcare Conference provides a platform for sharing stories, establishing meaningful connections, and managing time effectively. Learn how to navigate JPM with intentional networking ...

Paris-based biotechnology company Cellectis (NASDAQ: CLLS) has announced the first patient in the U.S. to receive a dose of its UCART22 allogeneic CAR T-cell therapy product candidate that was ...

David Reeser is one of the millions of Americans whose life has been changed by the ever-evolving, fast-growing epidemic of ...

Charles E. Hamner, Jr., Ph.D., a former president and CEO of the North Carolina Biotechnology Center and a longtime advocate for life sciences in the state, has received the 2024 High Flyer Champion ...

The Triangle is known as a hotbed for innovation, thanks in large part to the partnerships between multiple stakeholders, including universities, investors and ecosystem support organizations. In that ...

Radiopharmaceuticals, once a very niche drug class, are now on the brink of transforming cancer treatment and diagnostics, and North Carolina is at the heart of this change. These radioactive drugs ...

Research Triangle Park-based Opus Genetics, a clinical-stage gene therapy company devoted to treating inherited retinal diseases, has been acquired by a small ophthalmic biopharmaceutical firm with ...

SCHOTT Pharma USA, Inc., part of SHOTT Pharma AG, a global specialty glass manufacturer based in Germany, plans to invest $371 million over the next five years to build a new production facility in ...

AgBiome has developed and commercialized its biological agricultural products by striking up alliances with larger companies in the industry. Now the company has three more partnerships, two that will ...

The North Carolina Biotechnology Center was saddened to learn that Philip Benfey, Ph.D., an inspiring and pioneering plant geneticist and entrepreneur, passed away on Sept. 26 at the age of 70. Benfey ...

Durham-based EydisBio Inc. has received an Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for EYD-001, a treatment for systemic sclerosis. This rare and debilitating ...